Fol. Biol. 2015, 61, 91-96

https://doi.org/10.14712/fb2015061030091

Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants

Martin Beránek1,2, M. Drastíková2, J. Bureš3, V. Palička2

1Faculty of Pharmacy in Hradec Králové, Charles University in Prague and University Hospital Hradec Králové, Czech Republic
2Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine in Hradec Králové, Charles University in Prague and University Hospital Hradec Králové, Czech Republic
32nd Department of Internal Medicine, Faculty of Medicine in Hradec Králové, Charles University in Prague and University Hospital Hradec Králové, Czech Republic

Received March 2015
Accepted April 2015

References

1. Almoguera, B., Vazquez, L., Connolly, J. J., Bradfield, J., Sleiman, P., Keating, B., Hakonarson, H. (2014) Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes. Front. Genet. 5, 1-7. <https://doi.org/10.3389/fgene.2014.00096>
2. Ameyaw, M. M., Collie-Duguid, E. S., Powrie, R. H., Ofori-Adjei, D., McLeod, H. L. (1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum. Mol. Genet. 8, 367-370. <https://doi.org/10.1093/hmg/8.2.367>
3. Beránek, M., Drastíková, M., Dulíček, P., Palička, V. (2014) Preparing compound heterozygous reference material using gene synthesis technology: a model of thrombophilic mutations. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 158, 539-543. <https://doi.org/10.5507/bp.2014.041>
4. Burchard, P. R., Abou Tayoun, A. N., Lefferts, J. A., Lewis, L. D., Tsongalis, G. J., Cervinski, M. A. (2014) Development of a rapid clinical TPMT genotyping assay. Clin. Biochem. 47, 126-129. <https://doi.org/10.1016/j.clinbiochem.2014.07.088>
5. Chen, D., Yang, Z., Xia, H., Huang, J. F., Zhang, Y., Jiang, T. N., Wang, G. Y., Chuai, Z. R., Fu, W.L., Huang. Q. (2014) Enhanced specificity of TPMT*2 genotyping using unidirectional wild-type and mutant allele-specific scorpion primers in a single tube. PLoS One 9, e91824. <https://doi.org/10.1371/journal.pone.0091824>
6. Fakhoury, M., Andreu-Gallien, J., Mahr, A., Medard, Y., Azougagh, S., Vilmer, E., Jacqz-Aigrain, E. (2007) Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia? J. Clin. Pharm. Ther. 32, 633-639. <https://doi.org/10.1111/j.1365-2710.2007.00858.x>
7. Gearry, R. B., Barclay, M. L. (2005) Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J. Gastroenterol. Hepatol. 20, 1149-1157. <https://doi.org/10.1111/j.1440-1746.2005.03832.x>
8. Haglund, S., Lindqvist, M., Almer, S., Peterson, C., Taipalensuu, J. (2004) Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin. Chem. 50, 288-295. <https://doi.org/10.1373/clinchem.2003.023846>
9. Hughes, R. A., Miklos, A. E., Ellington, A. D. (2011) Gene synthesis: methods and applications. Methods Enzymol. 498, 277-309. <https://doi.org/10.1016/B978-0-12-385120-8.00012-7>
10. Krynetski, E. Y., Evans, W. E. (1999) Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm. Pharm. Res. 16, 342-349. <https://doi.org/10.1023/A:1011909315614>
11. MacDermott, R. P. (2015) 6-mercaptopurine (6-MP) metabolite monitoring and TPMT testing in the treatment of inflammatory bowel disease with 6-MP or azathioprine. UpToDate on line [Electronic version]. Available at: http://www.uptodate.com/contents/6-mercaptopurine-6-mp-metabolite-monitoring-and-tpmt-testing-in-the-treatment-ofinflammatory-bowel-disease-with-6-mp-or-azathioprine.
12. Pozler, O., Chládek, J., Malý, J., Hroch, M., Dědek, P., Beránek, M., Krásničanová, P. (2010) Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease. J. Crohns Colitis 4, 623-628. <https://doi.org/10.1016/j.crohns.2010.06.005>
13. Relling, M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C. H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., Hicks, J. K., Schwab, M., Klein, T. E. (2013) Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin. Pharmacol. Ther. 93, 324-325. <https://doi.org/10.1038/clpt.2013.4>
14. Roberts, R. L., Barclay, M. L., Gearry, R. B., Kennedy, M. A. (2004) A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations. Clin. Chim. Acta 341, 49-53. <https://doi.org/10.1016/j.cccn.2003.10.029>
15. Roman, M., Cabaleiro, T., Ochoa, D., Novalbos, J., Chaparro, M., Gisbert, J. P., Abad-Santos, F. (2012) Validation of a genotyping method for analysis of TPMT polymorphisms. Clin. Ther. 34, 878-884. <https://doi.org/10.1016/j.clinthera.2012.02.017>
16. Schutz, E., von Ahsen, N., Oellerich, M. (2000) Genotyping of eight thiopurine methyltransferase mutations: threecolor multiplexing, “two-color/shared” anchor, and fluorescence- quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design. Clin. Chem. 46, 1728-1737. <https://doi.org/10.1093/clinchem/46.11.1728>
17. Soltysova, A., Minarik, G., Dzurenkova, A., Sufliarska, S., Kadasi, L., Turna, J., Mladosievicova, B. (2011) APEX microarray panel for genotyping polymorphisms in cancer chemotherapy and estimation frequencies in a Slovak population. Pharmacogenomics 12, 577-592. <https://doi.org/10.2217/pgs.10.199>
18. Spire-Vayron de la Moureyre, C., Debuysere, H., Mastain, B., Vinner, E., Marez, D., Lo Guidice, J. M., Chevalier, D., Brique, S., Motte, K., Colombel, J. F., Turck, D., Noel, C., Flipo, R. M., Pol, A., Lhermitte, M., Lafitte, J. J., Libersa, C., Broly, F. (1998a) Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br. J. Pharmacol. 125, 879-887. <https://doi.org/10.1038/sj.bjp.0702152>
19. Spire-Vayron de la Moureyre, C., Debuysere, H., Sabbagh, N., Marez, D., Vinner, E., Chevalier, E. D., Lo Guidice, J. M., Broly, F. (1998b) Detection of known and new mutations in the thiopurine S-methyltransferase gene by singlestrand conformation polymorphism analysis. Hum. Mutat. 12, 177-185. <https://doi.org/10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO;2-E>
20. Tai, H. L., Krynetski, E. Y., Schuetz, E. G., Yanishevski, Y., Evans, W. E. (1997) Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc. Natl. Acad. Sci. USA 94, 6444-6449. <https://doi.org/10.1073/pnas.94.12.6444>
21. Yates, C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H. L., Pui, C. H., Relling, M. V., Evans, W. E. (1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 126, 608-614. <https://doi.org/10.7326/0003-4819-126-8-199704150-00003>
22. Zhou, S. F., Chowbay, B. (2007) Clinical significance of thiopurine S-methyltransferase gene polymorphisms. Curr. Pharmacogenomics 5, 103-115. <https://doi.org/10.2174/157016007780831808>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Archive